Moderna, Inc. (MRNA)

Moderna Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	1,723	2,595	1,927	2,907	3,205	6,848
Short-Term Investments	3,415	3,204	5,098	5,697	6,697	3,879
Cash & Short-Term Investments	5,138	5,799	7,025	8,604	9,902	10,727
Cash Growth	0.14%	-17.45%	-18.35%	-13.11%	-7.69%	132.79%
Accounts Receivable	17	184	358	892	1,385	3,175
Other Receivables	86	100	234	189	264	148
Receivables	103	284	592	1,081	1,685	3,323
Inventory	280	153	117	202	1,168	1,728
Prepaid Expenses	146	169	173	182	254	126
Other Current Assets	148	139	192	256	422	167
Total Current Assets	5,815	6,544	8,099	10,325	13,431	16,071
Property, Plant & Equipment	2,756	2,853	2,955	2,658	2,139	1,383
Long-Term Investments	1,772	2,342	2,508	4,743	8,360	6,843
Goodwill	52	52	52	52	-	-
Other Intangible Assets	109	45	40	44	-	-
Long-Term Deferred Tax Assets	82	81	81	-	982	326
Other Long-Term Assets	375	421	407	604	946	46
Total Assets	10,961	12,338	14,142	18,426	25,858	24,669

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	167	317	405	520	487	302
Accrued Expenses	1,468	827	898	1,069	1,828	1,472
Current Portion of Leases	52	42	37	25	196	211
Current Income Taxes Payable	-	-	-	-	48	876
Current Unearned Revenue	295	99	153	568	2,038	6,253
Other Current Liabilities	552	702	713	833	326	14
Total Current Liabilities	2,534	1,987	2,206	3,015	4,923	9,128
Long-Term Debt	591	590	-	-	-	-
Long-Term Leases	644	673	710	1,218	1,004	705
Long-Term Unearned Revenue	147	153	58	83	673	615
Other Long-Term Liabilities	284	285	267	256	135	76
Total Liabilities	4,200	3,688	3,241	4,572	6,735	10,524

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Additional Paid-In Capital	1,644	1,382	866	371	1,173	4,211
Retained Earnings	5,098	7,223	10,045	13,606	18,320	9,958
Comprehensive Income & Other	19	45	-10	-123	-370	-24
Total Common Equity	6,761	8,650	10,901	13,854	19,123	14,145
Shareholders' Equity	6,761	8,650	10,901	13,854	19,123	14,145
Total Liabilities & Equity	10,961	12,338	14,142	18,426	25,858	24,669

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	1,287	1,305	747	1,243	1,200	916
Net Cash (Debt)	5,623	6,830	8,772	12,038	17,020	16,654
Net Cash Growth	-16.87%	-22.14%	-27.13%	-29.27%	2.20%	232.41%
Net Cash Per Share	14.29	17.56	22.84	31.51	40.91	38.64
Filing Date Shares Outstanding	399.24	394.94	385.82	382.07	386.34	402.87
Total Common Shares Outstanding	399	394	386	382	385	403
Working Capital	3,281	4,557	5,893	7,310	8,508	6,943
Book Value Per Share	16.94	21.95	28.24	36.27	49.67	35.10
Tangible Book Value	6,600	8,553	10,809	13,758	19,123	14,145
Tangible Book Value Per Share	16.54	21.71	28.00	36.02	49.67	35.10
Land	77	78	59	22	11	-
Buildings	1,216	1,183	743	-	-	-
Machinery	795	777	525	445	343	211
Construction In Progress	279	298	1,057	860	281	212
Leasehold Improvements	409	403	207	522	460	313

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 31, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 28, 2026

Data Sources Report a data error